Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07SGS
|
||||
Former ID |
DNC007114
|
||||
Drug Name |
N-(4-(benzyloxy)phenethyl)pyridin-4-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528635] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H20N2O
|
||||
Canonical SMILES |
C1=CC=C(C=C1)COC2=CC=C(C=C2)CCNC3=CC=NC=C3
|
||||
InChI |
1S/C20H20N2O/c1-2-4-18(5-3-1)16-23-20-8-6-17(7-9-20)10-15-22-19-11-13-21-14-12-19/h1-9,11-14H,10,15-16H2,(H,21,22)
|
||||
InChIKey |
WPBRSJXCRWSAHJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [528635] | |
Glutamate [NMDA] receptor subunit epsilon 2 | Target Info | Inhibitor | [528635] | ||
KEGG Pathway | Ras signaling pathway | ||||
Rap1 signaling pathway | |||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Circadian entrainment | |||||
Long-term potentiation | |||||
Glutamatergic synapse | |||||
Dopaminergic synapse | |||||
Alzheimer's disease | |||||
Amyotrophic lateral sclerosis (ALS) | |||||
Huntington's disease | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Nicotine addiction | |||||
Alcoholism | |||||
Systemic lupus erythematosus | |||||
Pathway Interaction Database | ErbB4 signaling events | ||||
Reelin signaling pathway | |||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.